Conclusion This study demonstrates that pergolide, as an adjunct to levodopa, is a safe and effective antiparkinsonian agent that provides clinical improvement while permitting a reduction in levodopa dose. 结论协良行作为左旋多巴的联用药物,可明显改善帕金森病患者的临床症状及减少左旋多巴用量,且安全可靠。
Pharmacology and clinical evaluation of a new antiparkinsonian agent entacapone 抗帕金森病药物恩他卡朋的药理作用与临床评价